The AirCurve 11 is designed to tailor its therapy to a user’s normal breathing patterns. (ResMed) As Philips reaches a consent decree agreement with the FDA that will temporarily suspend its sales of ...

ResMed (NYSE: RMD) finds itself in an investment limbo as revolutionary weight loss drugs create both immediate opportunities and long-term existential questions for the sleep apnea device maker.

ResMed (RMD) shares fell in the premarket on Wednesday after Morgan Stanley downgraded the respiratory device maker, citing ...

Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...